VCA Japan Shiraishi Animal Hospital, 4-33-2 Sayamadai, Sayama, Saitama 350-1304, Japan.
VCA Japan Shiraishi Animal Hospital, 4-33-2 Sayamadai, Sayama, Saitama 350-1304, Japan.
J Vet Cardiol. 2022 Aug;42:74-82. doi: 10.1016/j.jvc.2022.06.001. Epub 2022 Jun 15.
Surgical mitral valve repair is a possible option for dogs with myxomatous mitral valve disease. However, information on surgical results and postoperative echocardiography is limited. This study aimed to verify the stage-specific surgical results of mitral valve repair and postoperative echocardiographic changes for two years following surgery.
Adult dogs (n = 55) treated with surgical mitral valve repair using the loop-in-loop technique were included in this study. Medical records were retrospectively reviewed.
Ninety percent of cases (50/55) survived to discharge, which survival was significantly decreased in myxomatous mitral valve disease advanced-stage dogs, Stage B2 (n = 14): 100%, Stage C (n = 27): 96.2%, and Stage D (n = 14): 71.4%. Significant reductions of overall heart size (vertebral heart score: preoperative 11.4 vs. post one month 10.2, P < 0.001), left atrium (left atrium to aortic root ratio: preoperative 2.3 vs. post one month 1.5, P < 0.001) and left ventricle (left ventricular end-diastolic diameter [normalized for bodyweight]: preoperative 2.2 vs. post one month 1.5, P < 0.001) were documented one month after surgery, showing successful management of mitral regurgitation. All medications for mitral valve disease were discontinued three months after surgery. The recurrence of mitral regurgitation was not evident during the two-year follow-up period.
Surgical mitral valve repair with the loop-in-loop technique is associated with significant decreases in indices of cardiac size at one-month post-repair. Disease stage influences operative survival after surgical mitral valve repair.
二尖瓣修复术是治疗黏液样变性二尖瓣疾病犬的一种可行选择。然而,有关手术结果和术后超声心动图的信息有限。本研究旨在验证二尖瓣修复的分期手术结果以及术后两年的超声心动图变化。
接受 Loop-in-Loop 技术二尖瓣修复术的成年犬(n=55)纳入本研究。回顾性审查病历。
90%的病例(50/55)存活至出院,黏液样变性二尖瓣疾病晚期(B2 期 n=14:100%、C 期 n=27:96.2%、D 期 n=14:71.4%)的存活率显著降低。心脏总体大小(椎体心脏评分:术前 11.4 与术后 1 个月 10.2,P<0.001)、左心房(左心房与主动脉根比值:术前 2.3 与术后 1 个月 1.5,P<0.001)和左心室(左心室舒张末期直径[体重归一化]:术前 2.2 与术后 1 个月 1.5,P<0.001)在术后 1 个月均显著降低,表明二尖瓣反流得到成功治疗。所有二尖瓣疾病药物在术后 3 个月停止使用。在两年的随访期间,未发现二尖瓣反流复发。
Loop-in-Loop 技术的二尖瓣修复术与术后 1 个月心脏大小指数的显著降低相关。疾病分期影响二尖瓣修复术后的手术存活率。